Evidence map›Paper›PMID 41181800›Full record

ArticleCureus2025

Impact of Proximity to an Academic Health Center on Adherence to the National Comprehensive Cancer Network (NCCN) Guidelines in Patients With Soft Tissue Sarcomas.

Zachary Butler, Dylan J Riley, Matthew Crosse, Steven Gitelis, Alan T Blank

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zachary ButlerOrthopedic Oncology, Rush University Medical Center, Chicago, USA.
Dylan J RileyOrthopedic Oncology, Rush University Medical Center, Chicago, USA.
Matthew CrosseOrthopedic Oncology, Rush University Medical Center, Chicago, USA.
Steven GitelisOrthopedic Oncology, Rush University Medical Center, Chicago, USA.
Alan T BlankOrthopedic Oncology, Rush University Medical Center, Chicago, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Soft tissue sarcomas (STS) are rare and complex malignancies. Due to their infrequency and complexity, the National Comprehensive Cancer Network (NCCN) provides evidence-based guidelines to guide the workup and treatment of STS. Adherence to these guidelines is crucial, as demonstrated by studies showing improved survival outcomes with compliance. However, factors influencing adherence, such as proximity to treatment centers, remain underexplored. This study aims to assess adherence to the NCCN guidelines at a single academic institution in 2023 and identify factors that affect compliance. Materials and methods We performed a retrospective review of patients diagnosed with or treated for STS at a single academic institution in 2023. In accordance with NCCN guidelines and based on tumor staging, we reviewed whether patients received the proper workup and treatment, including a history and physical examination, primary site imaging, core needle biopsy, chest/abdominal imaging, presentation to a multidisciplinary team, wide resection surgery, radiation therapy, and chemotherapy. Results A total of 43 patients were included in the study. The most common diagnoses were spindle cell sarcoma and undifferentiated pleomorphic sarcoma, each occurring in 10 patients (22.73% each). The most common TNM stage was IV in 22 patients (51.16%). All 43 patients (100%) met workup compliance according to the NCCN guidelines. Thirty-four patients (79.07%) completed their treatment course, adhering to the NCCN guidelines throughout. Two (4.65%) underwent a complete workup but were seen as second opinions and returned to their previous provider to complete their care. Three (6.98%) were recommended for further treatment of either radiation therapy or chemotherapy but declined. These cases had travel distances of 1.5, 10.9, and 22.5 miles, respectively. Four (9.30%) passed away while undergoing treatment. Travel distance ranged from 1.5 to 201 miles, with a median distance of 31 miles and a median travel time of 55 minutes. Conclusions Our findings demonstrate a high rate of compliance with NCCN guidelines at a single academic institution. Contrary to expectations, proximity to the cancer center did not significantly affect adherence. Further studies are needed to explore additional factors influencing non-compliance, such as socioeconomic and healthcare system barriers.

Indexed as

guideline adherencenccn guidelinesproximitysoft tissue sarcomatravel distancetreatment compliance

Identifiers

PMID41181800
PMCPMC12577144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.